Which super funds hold Organon & Co?
As at 31 December 2025, 15 Australian super investment options in our dataset held Organon & Co, the largest weighting being 0.03% in Overseas Shares (Accumulation) (CareSuper).
Options holding it
15
Largest weighting
0.03%
Overseas Shares (Accumulation) · CareSuper
Funds & options holding Organon & Co
Australian super investment options disclosing a holding in Organon & Co. Figures aggregate each option's disclosed line items for this security, as at each option's own reporting date.
| Fund | Phase | Option | Weighting | Value (AUD) | As at |
|---|---|---|---|---|---|
| CareSuper | Accumulation | Balanced (Accumulation) | 0.01% | $3,315,440 | 31 December 2025 |
| CareSuper | Accumulation | Growth (Accumulation) | 0.01% | $477,955 | 31 December 2025 |
| CareSuper | Accumulation | Overseas Shares (Accumulation) | 0.03% | $258,059 | 31 December 2025 |
| CareSuper | Retirement | Balanced (Income) | 0.01% | $200,943 | 31 December 2025 |
| CareSuper | Accumulation | Conservative Balanced (Accumulation) | 0.01% | $57,833 | 31 December 2025 |
| CareSuper | Retirement | Conservative Balanced (Income) | 0.01% | $56,845 | 31 December 2025 |
| CareSuper | Accumulation | Capital Stable (Accumulation) | 0.00% | $31,469 | 31 December 2025 |
| CareSuper | Retirement | Growth (Income) | 0.01% | $30,183 | 31 December 2025 |
| CareSuper | Retirement | Overseas Shares (Income) | 0.03% | $26,050 | 31 December 2025 |
| CareSuper | Retirement | Capital Stable (Income) | 0.00% | $22,971 | 31 December 2025 |
| CareSuper | Accumulation | Alternative Growth (Accumulation) | 0.01% | $10,180 | 31 December 2025 |
| CareSuper | Defined benefit | LCC HCC (Defined Benefit) | 0.01% | $5,442 | 31 December 2025 |
| CareSuper | Retirement | Long Term Pension (Income) | 0.00% | $4,072 | 31 December 2025 |
| CareSuper | Defined benefit | Quadrant (Defined Benefit) | 0.01% | $2,434 | 31 December 2025 |
| CareSuper | Retirement | Alternative Growth (Income) | 0.01% | $1,223 | 31 December 2025 |
This page surfaces figures disclosed by the funds themselves under Portfolio Holdings Disclosure (Schedule 8D), each as at the date shown. It is factual disclosure information, not financial advice or a recommendation.
Methodology — how holdings are sourced, resolved and aggregated.